Avricore Health Inc.
AVCR.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 3.49M | 3.47M | 3.30M | 2.95M | 2.58M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.49M | 3.47M | 3.30M | 2.95M | 2.58M |
| Cost of Revenue | 2.12M | 2.15M | 2.11M | 1.85M | 1.69M |
| Gross Profit | 1.37M | 1.32M | 1.19M | 1.09M | 890.40K |
| SG&A Expenses | 1.24M | 1.19M | 1.15M | 1.28M | 1.32M |
| Depreciation & Amortization | 2.20K | 1.90K | 1.90K | 2.00K | 1.70K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.36M | 3.34M | 3.26M | 3.14M | 3.02M |
| Operating Income | 130.90K | 126.60K | 40.30K | -192.00K | -436.20K |
| Income Before Tax | -475.80K | 77.00K | -4.20K | -255.30K | -521.90K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.48 | 0.08 | 0.00 | -0.26 | -0.52 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -475.80K | 77.00K | -4.20K | -255.30K | -521.90K |
| EBIT | 130.90K | 126.60K | 40.30K | -192.00K | -436.20K |
| EBITDA | 451.00K | 459.40K | 380.10K | 134.50K | -131.30K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.01 | 0.00 | 0.00 | 0.00 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 401.25M | 399.68M | 398.92M | 398.68M | 398.23M |
| Average Diluted Shares Outstanding | 406.98M | 405.41M | 404.66M | 398.68M | 398.23M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |